We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+8.81%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$35.5B
AUM Growth
+$2.23B
Cap. Flow
+$7.5M
Cap. Flow %
0.02%
Top 10 Hldgs %
40.39%
Holding
665
New
57
Increased
234
Reduced
272
Closed
65

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$215M
2
ACN icon
Accenture
ACN
+$184M
3
LLY icon
Eli Lilly
LLY
+$169M
4
UNH icon
UnitedHealth
UNH
+$159M
5
ELV icon
Elevance Health
ELV
+$150M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$388M
2
WFC icon
Wells Fargo
WFC
+$177M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$176M
4
KLAC icon
KLA
KLAC
+$118M
5
AVGO icon
Broadcom
AVGO
+$77.4M

Sector Composition

Rank Sector Weight
1 Technology 35.59%
2 Healthcare 23.31%
3 Communication Services 11.02%
4 Financials 10.34%
5 Consumer Discretionary 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$2.57B 7.24%
4,959,599
+99,660
+2% +$50.8M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$3.89T
$1.71B 4.81%
7,014,129
-839,267
-11% -$176M
META icon
3
Meta Platforms (Facebook)
META
$1.54T
$1.67B 4.71%
2,272,907
+46,880
+2% +$34.9M
AAPL icon
4
Apple
AAPL
$4.72T
$1.56B 4.4%
6,122,841
+148,795
+2% +$33.6M
LRCX icon
5
Lam Research
LRCX
$400B
$1.32B 3.71%
9,834,011
+156,371
+2% +$16.6M
JNJ icon
6
Johnson & Johnson
JNJ
$624B
$1.26B 3.56%
6,815,195
+260,764
+4% +$44.7M
ORCL icon
7
Oracle
ORCL
$346B
$1.18B 3.32%
4,185,731
-1,522,692
-27% -$388M
ABT icon
8
Abbott
ABT
$175B
$1.1B 3.09%
8,176,484
+361,946
+5% +$47.5M
TMO icon
9
Thermo Fisher Scientific
TMO
$213B
$1.04B 2.93%
2,141,863
+290,558
+16% +$135M
AVGO icon
10
Broadcom
AVGO
$1.87T
$927M 2.62%
2,810,749
-252,450
-8% -$77.4M
UNH icon
11
UnitedHealth
UNH
$385B
$921M 2.6%
2,666,623
+525,175
+25% +$159M
CRM icon
12
Salesforce
CRM
$129B
$903M 2.55%
3,810,635
+853,160
+29% +$215M
USB icon
13
US Bancorp
USB
$98.7B
$858M 2.42%
17,758,947
+1,189,525
+7% +$56.3M
TXN icon
14
Texas Instruments
TXN
$260B
$855M 2.41%
4,654,133
+38,828
+0.8% +$7.59M
V icon
15
Visa
V
$669B
$833M 2.35%
2,439,988
+13,920
+0.6% +$4.82M
ACN icon
16
Accenture
ACN
$84.9B
$827M 2.33%
3,353,854
+705,290
+27% +$184M
ELV icon
17
Elevance Health
ELV
$82.3B
$815M 2.3%
2,523,450
+483,340
+24% +$150M
AMZN icon
18
Amazon
AMZN
$2.51T
$788M 2.22%
3,586,913
-18,894
-0.5% -$4.28M
MRK icon
19
Merck
MRK
$322B
$556M 1.57%
6,625,350
+155,777
+2% +$12.8M
LLY icon
20
Eli Lilly
LLY
$1.06T
$535M 1.51%
700,608
+226,586
+48% +$169M
UBER icon
21
Uber
UBER
$140B
$534M 1.51%
5,452,913
+25,077
+0.5% +$2.35M
TJX icon
22
TJX Companies
TJX
$170B
$528M 1.49%
3,652,215
+5,019
+0.1% +$667K
WFC icon
23
Wells Fargo
WFC
$261B
$527M 1.49%
6,287,235
-2,182,531
-26% -$177M
HLT icon
24
Hilton Worldwide
HLT
$72.9B
$523M 1.48%
2,016,751
+20,702
+1% +$5.6M
ISRG icon
25
Intuitive Surgical
ISRG
$119B
$510M 1.44%
1,139,659
+50,378
+5% +$24.2M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2025 Portfolio in Review

As of Q3 2025, Grantham, Mayo, Van Otterloo & Co (GMO) held 665 positions worth $35.5B, up 6.7% from $33.2B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2025 filing shows 57 new, 234 increased, 272 reduced and 65 closed positions. Its largest new stake was Clean Harbors: 124,557 shares worth $28.9M. The largest sale was Oracle, an estimated $388M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Communication Services.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2025 buy was Clean Harbors: 124,557 shares worth $28.9M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Salesforce in Q3 2025, an estimated $215M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2025 reduction was Oracle, cutting an estimated $388M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited The AZEK Co in Q3 2025, selling an estimated $40.5M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $35.5B portfolio in Q3 2025.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 57 new positions and closed 65 in Q3 2025.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 6.7% quarter-over-quarter to $35.5B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2025, filed 13 Nov 2025.